Concise Review: Using Fat to Fight Disease: A Systematic Review of Nonhomologous Adipose‐Derived Stromal/Stem Cell Therapies

The objective of this Review is to describe the safety and efficacy of adipose stem/stromal cells (ASC) and stromal vascular fraction (SVF) in treating common diseases and the next steps in research that must occur prior to clinical use. Pubmed, Ovid Medline, Embase, Web of Science, and the Cochrane Library were searched for articles about use of SVF or ASC for disease therapy published between 2012 and 2017. One meta‐analysis, 2 randomized controlled trials, and 16 case series were included, representing 844 human patients. Sixty‐nine studies were performed in preclinical models of disease. ASCs improved symptoms, fistula healing, remission, and recurrence rates in severe cases of inflammatory bowel disease. In osteoarthritis, ASC and SVF improved symptom‐related, functional, radiographic, and histological scores. ASC and SVF were also shown to improve clinical outcomes in ischemic stroke, multiple sclerosis, myocardial ischemia, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, chronic liver failure, glioblastoma, acute kidney injury, and chronic skin wounds. These effects were primarily paracrine in nature and mediated through reduction of inflammation and promotion of tissue repair. In the majority of human studies, autologous ASC and SVF from liposuction procedures were used, minimizing the risk to recipients. Very few serious, treatment‐related adverse events were reported. The main adverse event was postprocedural pain. SVF and ASC are promising therapies for a variety of human diseases, particularly for patients with severe cases refractory to current medical treatments. Further randomized controlled trials must be performed to elaborate potential safety and efficacy prior to clinical use. Stem Cells 2018;36:1311–1328Mesenchymal stem cells maintain homeostasis and may treat common diseases through homing, differentiation, and paracrine effects.Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/146316/1/stem2847_am.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/146316/2/stem2847.pd

Phoenix Y6

The mission of this project is to design and fabricate a vertical take-off and landing (VTOL) fixed-wing drone for use by firefighters and other emergency services. This vehicle will be designed for uses that include surveying wildfires, as well as spotting vehicular accidents, urban fires, and floods. Current drones available on the market are expensive or not designed specifically for emergency response. Our goal is to develop a working prototype of a vehicle that will be able to collect and relay important data such as live video and thermal images in addition to other measurements such as air velocity and humidity

Volume 32, Number 2, June 2012 OLAC Newsletter

Digitized June 2012 issue of the OLAC Newsletter

Volume 32, Number 4, December 2012 OLAC Newsletter

Digitized December 2012 issue of the OLAC Newsletter

Volume 32, Number 1, March 2012 OLAC Newsletter

Digitized March 2012 issue of the OLAC Newsletter

Volume 32, Number 3, September 2012 OLAC Newsletter

Digitized September 2012 issue of the OLAC Newsletter

Volume 33, Number 2, June 2013 OLAC Newsletter

Digitized June 2013 issue of the OLAC Newsletter

Volume 33, Number 1, March 2013 OLAC Newsletter

Digitized March 2013 issue of the OLAC Newsletter

Obesity Associated Alterations in the Biology of Adipose Stem Cells Mediate Enhanced Tumorigenesis by Estrogen Dependent Pathways

Introduction: Obesity has been associated with increased incidence and mortality of breast cancer. While the precise correlation between obesity and breast cancer remains to be determined, recent studies suggest that adipose tissue and adipose stem cells (ASCs) influence breast cancer tumorigenesis and tumor progression. Methods: Breast cancer cells lines were co-cultured with ASCs (n = 24), categorized based on tissue site of origin and body mass index (BMI), and assessed for enhanced proliferation, alterations in gene expression profile with PCR arrays, and enhanced tumorigenesis in immunocompromised mice. The gene expression profile of ASCs was assess with PCR arrays and qRT-PCR and confirmed with Western blot analysis. Inhibitory studies were conducted by delivering estrogen antagonist ICI182,780, leptin neutralizing antibody, or aromatase inhibitor letrozole and assessing breast cancer cell proliferation. To assess the role of leptin in human breast cancers, Oncomine and Kaplan Meier plot analyses were conducted. Results: ASCs derived from the abdominal subcutaneous adipose tissue of obese subjects (BMI \u3e 30) enhanced breast cancer cell proliferation in vitro and tumorigenicity in vivo . These findings were correlated with changes in the gene expression profile of breast cancer cells after co-culturing with ASCs, particularly in estrogen receptor-alpha (ESR1) and progesterone receptor (PGR) expression. Analysis of the gene expression profile of the four groups of ASCs revealed obesity induced alterations in several key genes, including leptin (LEP). Blocking estrogen signaling with ICI182,780, leptin neutralizing antibody, or letrozole diminished the impact of ASCs derived from obese subjects. Women diagnosed with estrogen receptor/progesterone receptor positive (ER+/PR+) breast cancers that also expressed high levels of leptin had poorer prognosis than women with low leptin expression. Conclusion: ASCs isolated from the abdomen of obese subjects demonstrated increased expression of leptin, through estrogen stimulation, which increased breast cancer cell proliferation. The results from this study demonstrate that abdominal obesity induces significant changes in the biological properties of ASCs and that these alterations enhance ER+/PR+ breast cancer tumorigenesis through estrogen dependent pathways